Owners, management and financials
CVR: 32672620
Previous names: AC 01 ApS
DKK -68,061
Gross profit
Net result: DKK 206,285
Beier Holding ApS (100%)
CVR · view owners
Henrik Beier Jessen
CVR · view management
Active
Founded 15 January 2010
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Bios I Pharma ApS
CVR · 28/09/2026
View the full event history
Bios I Pharma ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AC 01 ApS. The management consists of Henrik Beier Jessen. The company is owned by Beier Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -68,061 and a net result of DKK 206,285 compared with DKK 1,732,448 the year before. Equity in the 2025 report amounted to DKK 445,202.
Selskabets formål er at udføre forskning og eksperimentel udvikling inden for naturvidenskab og teknik.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | -68 t. | 206 t. | 3.8 mio. | 445 t. | 0 | |
| 202401/10/2023 – 30/09/2024 | 2 mio. | 1.7 mio. | 3.9 mio. | 239 t. | 0 | |
| 202301/10/2022 – 30/09/2023 | -1 t. | 352 t. | 1.8 mio. | -3 mio. | 0 | |
| 202201/10/2021 – 30/09/2022 | 48 t. | 10 t. | 1.9 mio. | -3.3 mio. | - | |
| 202101/10/2020 – 30/09/2021 | 775 | -68 t. | 1.9 mio. | -3.4 mio. | - | |
| 201901/01/2019 – 31/12/2019 | -610 t. | -614 t. | 1.8 mio. | -3.2 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -10 t. | -103 t. | 0 | -2.6 mio. | 0 | |
| 201701/01/2017 – 31/12/2017 | -579 t. | -2.6 mio. | 15 t. | -2.5 mio. | 0 | |
| 201601/07/2015 – 30/06/2016 | -6 t. | -2 t. | 124 t. | 112 t. | - | |
| 201501/07/2014 – 30/06/2015 | -7 t. | -2 t. | 126 t. | 113 t. | - | |
| 201401/07/2013 – 30/06/2014 | -7 t. | -2 t. | 122 t. | 116 t. | - | |
| 201301/07/2012 – 30/06/2013 | -7 t. | -4 t. | 137 t. | 118 t. | - |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Bios I Pharma ApS is 32672620.
Bios I Pharma ApS is owned by Beier Holding ApS.
The management of Bios I Pharma ApS consists of Henrik Beier Jessen.
In 2025, Bios I Pharma ApS reported a gross profit of DKK -68,061.
Bios I Pharma ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Bios I Pharma ApS was founded on 15 January 2010.
Claim this page to add your logo and social links. Free to get started.
Address changed to Palle Juul-Jensens Boulevard 82, 8200 Aarhus N (September 28, 2026).
Contact info changed: new phone: 30731077, new email: [email protected] (September 28, 2026).
On September 28, 2026, the company changed its name from AC 01 ApS to Bios I Pharma ApS.
Contact info changed: new phone: 30731077, new email: [email protected] (February 20, 2026).
Contact info changed: new phone: 30731077, new email: [email protected] (February 19, 2026).
Bios I Pharma ApS has published its annual report for 2025. Gross profit came to DKK -68,061, and the net result was DKK 206,285.
As of February 19, 2026, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
Bios I Pharma ApS has published its annual report for 2024. Gross profit came to DKK 2,012,494, and the net result was DKK 1,732,448.
As of May 14, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of May 14, 2025, Henrik Beier Jessen is registered as director of Bios I Pharma ApS.
As of May 5, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
As of May 5, 2025, Henrik Beier Jessen has stepped down as director of Bios I Pharma ApS.
Bios I Pharma ApS has published its annual report for 2023. Gross profit came to DKK -1,282, and the net result was DKK 351,852.
As of January 17, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of January 17, 2024, TØNDER REVISION, GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Bios I Pharma ApS.
Bios I Pharma ApS has published its annual report for 2022. Gross profit came to DKK 48,269, and the net result was DKK 9,853.
As of January 12, 2023, TØNDER REVISION, GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Bios I Pharma ApS.
Bios I Pharma ApS has published its annual report for 2021. Gross profit came to DKK 775, and the net result was DKK -67,899.
Bios I Pharma ApS has published its interim report for the period January 1, 2020 to September 30, 2020.
Bios I Pharma ApS has published its annual report for 2019. Gross profit came to DKK -610,187, and the net result was DKK -614,323.
Bios I Pharma ApS has published its annual report for 2018. Gross profit came to DKK -10,482, and the net result was DKK -103,496.
As of July 31, 2018, Beier Holding ApS is registered as an owner of Bios I Pharma ApS with an ownership share of 100%.
Bios I Pharma ApS has published its annual report for 2017. Gross profit came to DKK -578,658, and the net result was DKK -2,578,658.
As of June 13, 2018, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
As of June 22, 2017, Henrik Beier Jessen is registered as director of Bios I Pharma ApS.
As of June 22, 2017, Jens Henrik Haaning has stepped down as director of Bios I Pharma ApS.
Bios I Pharma ApS has published its interim report for the period July 1, 2016 to December 31, 2016.
As of November 14, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of November 14, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
As of November 14, 2016, Jens Henrik Haaning is registered as director of Bios I Pharma ApS.
As of November 14, 2016, Henrik Lasse Lindblad has stepped down as director of Bios I Pharma ApS.
Bios I Pharma ApS has published its annual report for 2016. Gross profit came to DKK -6,275, and the net result was DKK -1,621.
Bios I Pharma ApS has published its annual report for 2015. Gross profit came to DKK -7,025, and the net result was DKK -2,341.
Bios I Pharma ApS has published its annual report for 2014. Gross profit came to DKK -6,875, and the net result was DKK -2,385.
Bios I Pharma ApS has published its annual report for 2013. Gross profit came to DKK -7,250, and the net result was DKK -3,950.
As of February 15, 2012, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of February 15, 2012, DKNF 387 ApS has stepped down as auditor of Bios I Pharma ApS.
As of November 11, 2011, DKNF 387 ApS has been appointed auditor of Bios I Pharma ApS.
As of October 3, 2011, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Bios I Pharma ApS.
As of May 18, 2011, Henrik Lasse Lindblad is registered as director of Bios I Pharma ApS.
As of May 18, 2011, Michael Bødker Friis has stepped down as adm. dir. of Bios I Pharma ApS.
As of September 27, 2010, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Bios I Pharma ApS.
As of September 27, 2010, VICH 2938 A/S has stepped down as auditor of Bios I Pharma ApS.
As of May 25, 2010, Michael Bødker Friis is registered as adm. dir. of Bios I Pharma ApS.
As of May 25, 2010, Lars Aabo has stepped down as adm. dir. of Bios I Pharma ApS.
As of January 15, 2010, VICH 2938 A/S has been appointed auditor of Bios I Pharma ApS.
As of January 15, 2010, Lars Aabo is registered as adm. dir. of Bios I Pharma ApS.
Bios I Pharma ApS was founded on January 15, 2010.
Companies in the same industry and area
CVR 26119898
CVR 36899069
CVR 41058439
CVR 46253272
CVR 10403782
